Compound
pectin
High molecular weight polysaccharides present in the cell walls of all plants. Pectins cement cell walls together. They are used as emulsifiers and stabilizers in the food industry. They have been tried for a variety of therapeutic uses including as antidiarrheals, where they are now generally considered ineffective, and in the treatment of hypercholesterolemia.
Studied for
3 endpoints · 3 findings · 1 paper
- HDL cholesterolraisesEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.
- LDL cholesterollowersEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.
- Total cholesterol (TC)lowersEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.
What the evidence says
How to read these marks3 findings · 3 endpoints · 1 paper · by evidence strength
What moved
3 findings
Increases HDL cholesterol
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“In pigs fed with pectin, total cholesterol and low-density lipoprotein cholesterol (LDL-C) were lowered but high-density lipoprotein (HDL-C) was increased (P < 0.05).”
Quoted verbatim from Effects of dietary pectin on the profile and transport of intestinal bile acids in young pigs.. - Study
- animal · not in humans
- Duration
- 2 months
- Dose
- 5% pectin in diet
- Population
- Young pigs fed corn-soybean meal diets with 5% pectin or cornstarch control for 72 days
Effects of dietary pectin on the profile and transport of intestinal bile acids in young pigs.2018PMID:30102377Permalink
Decreases total cholesterol (TC)
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“In pigs fed with pectin, total cholesterol and low-density lipoprotein cholesterol (LDL-C) were lowered but high-density lipoprotein (HDL-C) was increased (P < 0.05).”
Quoted verbatim from Effects of dietary pectin on the profile and transport of intestinal bile acids in young pigs.. - Study
- animal · not in humans
- Duration
- 2 months
- Dose
- 5% pectin in diet
- Population
- Young pigs fed corn-soybean meal diets with 5% pectin or cornstarch control for 72 days
Effects of dietary pectin on the profile and transport of intestinal bile acids in young pigs.2018PMID:30102377Permalink
Decreases LDL cholesterol
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“In pigs fed with pectin, total cholesterol and low-density lipoprotein cholesterol (LDL-C) were lowered but high-density lipoprotein (HDL-C) was increased (P < 0.05).”
Quoted verbatim from Effects of dietary pectin on the profile and transport of intestinal bile acids in young pigs.. - Study
- animal · not in humans
- Duration
- 2 months
- Dose
- 5% pectin in diet
- Population
- Young pigs fed corn-soybean meal diets with 5% pectin or cornstarch control for 72 days
Effects of dietary pectin on the profile and transport of intestinal bile acids in young pigs.2018PMID:30102377Permalink
On the label
Labelled products
50 products
Source: NIH DSLD · Ingredient: pectin · 50 products · Declared amount per serving: 5–1,000 mg (43 products)
47 labels state an amount3 do not
- BioGenesis NutraceuticalsOnco-X1,000 mgper 3 Capsule(s)DSLD:21555
- Body Dynamics MaXzorb NutritionRaw Mega Nutritional Vitamin system5 mgper 4 Tablet(s)DSLD:230958
- Catie'sGreens400 mgper 10.89 Gram(s)DSLD:22208
- D'Adamo Personalized NutritionDeflect ABCitrus aurantium70 mgper 2 Capsule(s)DSLD:287132
- DaVinci LaboratoriesSpectra Man12.5 mgper 2 Tablet(s)DSLD:313254
- DaVinci LaboratoriesSpectra Woman12.5 mgper 2 Tablet(s)DSLD:322208
- DaVinci Laboratories Of VermontSpectra Man12.5 mgper 2 Tablet(s)DSLD:23644
- DaVinci Laboratories Of VermontSpectra Without Copper And Iron12.5 mgper 2 Tablet(s)DSLD:23690
- DetoxifyMighty Clean Herbal Cleanse Tropical Flavor750 mgper 237 mLDSLD:299350
- DetoxifyReady Clean Herbal Cleanse Tropical Flavor86 mgper 473 mLDSLD:299354
- DetoxifyXxtra Clean Herbal Cleanse Tropical Flavor107 mgper 591 mLDSLD:299356
- Douglas LaboratoriesEssential-4 Nutrition Pack25 mgper 1 Packet(s)DSLD:10038
Show the remaining 38
- Douglas LaboratoriesLongevity Support Pack25 mgper 1 Packet(s)DSLD:28500
- Douglas LaboratoriesModified Citrus Pectin5 gper 5 Gram(s)DSLD:10079
- Douglas LaboratoriesSenior Women's Pack25 mgper 1 Packet(s)DSLD:5155
- Douglas LaboratoriesUltra Cardio Support Pack25 mgper 1 Packet(s)DSLD:27277
- Douglas LaboratoriesUltra Preventive IX50 mgper 7 Tablet(s)DSLD:10662
- Douglas LaboratoriesUltra Preventive IX50 mgper 7 Tablet(s)DSLD:10250
- Douglas LaboratoriesUltra Preventive World Formula6.25 mgper 2 Vegetarian Capsule(s)DSLD:10716
- Douglas LaboratoriesWeek Four: Repair25 mgper 2 Packet(s)DSLD:6220
- Dr. MercolaWhole-Food Multivitamin plus Vital Minerals for Women50 mgper 8 Tablet(s)DSLD:232992
- DrFormulasNexazyme Apple Cider Vinegar 1300 mg25 mgper 1 Capsule(s)DSLD:295244
- Drucker LabsintraMAX 2.0 Peach Mango FlavorApple Pectin PlantPart: fruit Note: fiberamount not statedper 1 fl. Oz.DSLD:210630
- Drucker LabsintraMAX 2.0 Peach Mango FlavorApple Pectin PlantPart: fruit Note: fiberamount not statedper 1 fl. Oz.DSLD:236722
- ecoNugenicsPectaClearCitrus Pectin, Modified1.5 Gram(s)per 1 Capsule(s)DSLD:293082
- ecoNugenicsPectasol Modified Citrus Pectin Lime Infusion PowderCitrus Pectin, Modified5 Gram(s)per 6.13 Gram(s)DSLD:293089
- ecoNugenicsPectasol Modified Citrus Pectin Tangerine Infusion ChewablesCitrus Pectin, Modified2.4 Gram(s)per 2 Tablet(s)DSLD:293090
- Good 'N NaturalPotent Probiotic Acidophilus With Pectin200 mgper 2 Capsule(s)DSLD:10632
- Holistic Labs Ltd.Energize Greensamount not statedper 8.45 TbspDSLD:175508
- IVL Institute For Vibrant LivingGo Ruby Go!275 mgper 8.5 Gram(s)DSLD:15443
- Natural Factors VegiDayVegan Organic All in One Shake & Go French Vanilla300 mgper 43 Gram(s)DSLD:220527
- Nature's PlusChewable NutraSec30 mgper 1 Tablet(s)DSLD:14136
- Nature's PlusSource Of Life Capsules20 mgper 9 Capsule(s)DSLD:69271
- Nature's PlusSource of Life RED20 mgper 6 Tablet(s)DSLD:49848
- Nature's PlusSource Of Life Red20 mgper 6 Tablet(s)DSLD:15072
- Nature's PlusSource of Life With Whole Food Concentrates No Iron20 mgper 3 Tablet(s)DSLD:49708
- NOWSpecial Two25 mgper 4 Vcap(s)(R)DSLD:29122
- Nutri-WestTotal Chelate50 mgper 1 Tablet(s)DSLD:28424
- Priority One Nutritional SupplementsEnvironmental Defense 1Malus pumila150 mgper 3 Vegetarian Capsule(s)DSLD:277354
- Priority One Nutritional SupplementsReflux Soothe100 mgper 1 Tablet(s)DSLD:277410
- SolaraySuper Bio C Buffered30 mgper 2 Vegetarian Capsule(s)DSLD:277617
- SolgarEarth Source Multi-Nutrient25 mgper 3 Tablet(s)DSLD:214014
- SolgarEarth Source Multi-Nutrient25 mgper 3 Tablet(s)DSLD:263856
- SolgarEarth Source Multi-Nutrient25 mgper 3 Tablet(s)DSLD:81624
- Sun TenYin Essentials100 mgper 4 Tablet(s)DSLD:64361
- SwansonMulti Vitamin and Mineral without Iron20 mgper 3 Tablet(s)DSLD:308674
- The Vitamin ShoppeApple Cider Vinegar with Apple Pectin27 mgper 1 Tablet(s)DSLD:221409
- The Vitamin ShoppeApple Cider Vinegar with Apple Pectin27 mgper 1 Tablet(s)DSLD:221417
- The Vitamin ShoppeApple Cider Vinegar With Apple Pectin27 mgper 1 Tablet(s)DSLD:35850
- VitaScriptVitamin C CompleteFruit30 mgper 2 Capsule(s)DSLD:283134
Label record: NIH Office of Dietary Supplements · CC0
Registered, and not reported
- Source
- ClinicalTrials.gov
- Intervention
- pectin
- Status
- Completed, terminated or suspended
- Results posted
- No
Trials without posted results
66 trials
66 registered trials without posted results · Overdue (FDAAA 801): 62
62 past the window4 within it, or no actual date
- NCT06426134completed2026-04-17a university or hospital
- NCT06818032completed2026-03-26a university or hospital
- NCT04723472suspended— Want to modify the study furtherexpected 2025-12-31a university or hospital
- NCT05647278completed2025-09-30a university or hospitalpast the reporting window
- NCT06340334completed2025-09-01a university or hospitalpast the reporting window
- NCT06885632completed2025-05-15industrypast the reporting window
- NCT06676111completed2025-02-10industrypast the reporting window
- NCT07792512completed2025-02-05a university or hospitalpast the reporting window
- NCT07499960completed2024-08-30a university or hospitalpast the reporting window
- NCT06480799completed2024-08-28a university or hospitalpast the reporting window
- NCT06823791completed2024-07-30a university or hospitalpast the reporting window
- NCT05931471completed2024-06-21US federal agencypast the reporting window
Show the remaining 54
- NCT05354245completed2024-06-10a university or hospitalpast the reporting window
- NCT05431075completed2024-02-01a university or hospitalpast the reporting window
- NCT06045494completed2024-01-16industrypast the reporting window
- NCT05449665terminated— There were issues with recruitment so study was stopped2023-12-31a university or hospitalpast the reporting window
- NCT06758570completed2023-12-31a university or hospitalpast the reporting window
- NCT07321184completed2023-11-30a university or hospitalpast the reporting window
- NCT05900609completed2023-11-26a university or hospitalpast the reporting window
- NCT06018740completed2023-11-06industrypast the reporting window
- NCT05421793completed2023-07-30a university or hospitalpast the reporting window
- NCT05049902completed2023-05-30a university or hospitalpast the reporting window
- NCT05696938completed2023-04-26a government bodypast the reporting window
- NCT07408271completed2023-03-24a university or hospitalpast the reporting window
- NCT07194954completed2023-03-01a university or hospitalpast the reporting window
- NCT06386081completed2023-01-31a university or hospitalpast the reporting window
- NCT03317678completed2022-12-07a university or hospitalpast the reporting window
- NCT05407701completed2022-11-15a university or hospitalpast the reporting window
- NCT06580132completed2022-09-09a university or hospitalpast the reporting window
- NCT04850209completed2022-08-10a university or hospitalpast the reporting window
- NCT05333315completed2022-07-01a university or hospitalpast the reporting window
- NCT06300021completed2022-05-20industrypast the reporting window
- NCT04923113completed2022-01-31a university or hospitalpast the reporting window
- NCT04660123completed2021-12-30a university or hospitalpast the reporting window
- NCT03495375completed2021-05-20a university or hospitalpast the reporting window
- NCT04209933completed2020-08-01a university or hospitalpast the reporting window
- NCT05350579terminated— Due to the onset of the COVID-19 pandemic2020-03-25a university or hospitalpast the reporting window
- NCT03542786completed2020-02-29industrypast the reporting window
- NCT01681823completed2020-01industrypast the reporting window
- NCT03658746completed2019-12-31a university or hospitalpast the reporting window
- NCT03731065completed2019-10-30a university or hospitalpast the reporting window
- NCT03716622completed2019-08-31a university or hospitalpast the reporting window
- NCT03444311terminated— Low tolerability of fibers included in the product2019-07-02industrypast the reporting window
- NCT04884464completed2019-06-30a university or hospitalpast the reporting window
- NCT04386226completed2019-03-15a university or hospitalpast the reporting window
- NCT01960946completed2018-08-30a university or hospitalpast the reporting window
- NCT02164877terminated— Not enough participants enrolled2017-05a university or hospitalpast the reporting window
- NCT02844426completed2016-06a university or hospitalpast the reporting window
- NCT01756651completed2016-05-10a university or hospitalpast the reporting window
- NCT02376270completed2016-05a university or hospitalpast the reporting window
- NCT01946555completed2015-12a university or hospitalpast the reporting window
- NCT02838849completed2015-12a university or hospitalpast the reporting window
- NCT02379624completed2015-01a university or hospitalpast the reporting window
- NCT02050503completed2014-06a university or hospitalpast the reporting window
- NCT01961869completed2014-05-14a university or hospitalpast the reporting window
- NCT02270268completed2013-10a university or hospitalpast the reporting window
- NCT01717248completed2013-06industrypast the reporting window
- NCT02194972completed2012-10a university or hospitalpast the reporting window
- NCT01427426completed2012-05a university or hospitalpast the reporting window
- NCT01479907completed2012-03a university or hospitalpast the reporting window
- NCT01526759completed2012-03a university or hospitalpast the reporting window
- NCT01257295completed2011-05a university or hospitalpast the reporting window
- NCT00753558completed2010-06a university or hospitalpast the reporting window
- NCT01005342completed2007-06a university or hospitalpast the reporting window
- NCT00184522completed2004-11a university or hospitalpast the reporting window
- NCT00277147completedno completion dateNIH
Papers screened
961 papers
- Compound
- pectin
- Screened
- 961
- Admitted
- 1
- Discarded
- 533
- Not read
- 427
- Showing
- 200 of 961
Produced a finding1 paper
- PMID:301023772026-10-05
Discarded: the wrong intervention494 papers
- PMID:31816861no claim extracted — combination_exposure2026-09-29
- PMID:11606552cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:12917293cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:15173565cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:15315638cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:15927942cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:16460513cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:17585298cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:17932308cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:18036197cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:18065554cited by PMID:40307219; not about the subject it would be filed under2026-09-29
- PMID:18216856cited by PMID:40307219; not about the subject it would be filed under2026-09-29
and 482 more.
Discarded: no extractable result20 papers
- PMID:21494626claims extracted but refused by the deterministic validators2026-10-05
- PMID:24236183claims extracted but the two passes did not agree2026-10-05
- PMID:25602757claims extracted but refused by the deterministic validators2026-10-05
- PMID:26447990claims extracted but refused by the deterministic validators2026-10-05
- PMID:27829066claims extracted but the two passes did not agree2026-10-05
- PMID:31270370claims extracted but refused by the deterministic validators2026-09-29
- PMID:34835981claims extracted but the two passes did not agree2026-09-29
and 13 more.
Discarded: not retrievable10 papers
- PMID:33615384no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-09-29
- PMID:4269305no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-09-29
and 8 more.
Discarded: an endpoint this vocabulary does not hold7 papers
- PMID:19109874no claim extracted — no_outcome_node — measured: number of liver metastases per mouse after intrasplenic CT26 colon cancer cell injection; implanted spleen tumour volume, cm3 | number of liver metastases per mouse and implanted spleen tumour volume in cm3, mouse colon cancer model2026-10-05
- PMID:23392255claims extracted but the object named resolved to no node — recorded in candidate_nodes (ADR-0070)2026-10-05
- PMID:25973610no claim extracted — no_outcome_node — measured: body weight gain over a 3-week feeding period, grams; epididymal fat pad weight, g; liver fat, g; caecal short-chain fatty acid pool, GC | body weight gain over three weeks in grams, rats2026-10-05
- PMID:27815266no claim extracted — no_outcome_node — measured: osteogenic-marker and Gal-3 protein expression in cultured human valvular interstitial cells, western blot; IL-6 secretion into cell supernatant, ELISA | interleukin-6 secretion into cell-culture supernatant, ELISA2026-10-05
- PMID:28758988no claim extracted — no_outcome_node — measured: aortic media thickness / aortic tissue fibrosis and calcification marker expression in pressure-overload rats, histology and qPCR | aortic media thickness, histology on haematoxylin/eosin sections2026-10-05
- PMID:28797814no claim extracted — no_outcome_node — measured: in vitro cell migration inhibition, scratch-assay relative migration distance and Transwell absorbance at 570 nm | in vitro cell migration, scratch-wound width and Transwell absorbance at 570 nm2026-10-05
and 1 more.
Discarded: another reason, stated per paper2 papers
and 2 more.
Not read yet427 papers
- PMID:200451142026-10-04
- PMID:170759782026-10-01
- PMID:17071492026-09-29
- PMID:210469292026-09-29
- PMID:274354402026-09-29
- PMID:278539842026-09-29
- PMID:308964152026-09-29
- PMID:349598472026-09-29
- PMID:353980512026-09-29
- PMID:376307242026-09-29
- PMID:117061812026-09-29
- PMID:123685062026-09-29
and 415 more.
Measured, not recorded
- Compound
- pectin
- Endpoints measured
- 491 endpoints
- Recorded as a finding
- No
Show what was measured
Galectin-3 expression in liver metastases
no effect
Except for the negative control group, the expression of galectin-3 in liver metastases of the other 4 groups showed no significant difference
PMID:19109874 · one of two readings recorded this
Median volume of implanted spleen tumor
decreases, n = 60
Except for the negative group, the median volume of implanted spleen tumor in the other 4 groups was 1.51 cm(3), 0.93 cm(3), 0.77 cm(3) and 0.70 cm(3), respectively
PMID:19109874 · one of two readings recorded this
number of liver metastases and implanted spleen tumour volume in a CT26 colon cancer liver metastasis model in Balb/c mice; serum galectin-3 by ELISA
decreases, number of liver metastases significantly less in the high MCP concentration group than in the positive control group, p = 0.008
Not recorded as a finding: this platform holds no node for the endpoint
The number of liver metastases in high MCP concentration group was significantly less than that in positive control group (P = 0.008).
PMID:19109874 · one of two readings recorded this
number of liver metastases and implanted spleen tumour volume in Balb/c mice with CT26 colon cancer given modified citrus pectin 1.0, 2.5 or 5.0% in drinking water versus 0%; serum galectin-3 by ELISA
decreases, number of liver metastases in the high MCP group significantly less than in the positive control group, P = 0.008, p = 0.008
Not recorded as a finding: this platform holds no node for the endpoint
The number of liver metastases in high MCP concentration group was significantly less than that in positive control group (P = 0.008).
PMID:19109874 · one of two readings recorded this
Number of liver metastases
decreases, p = 0.008
The number of liver metastases in high MCP concentration group was significantly less than that in positive control group (P = 0.008)
PMID:19109874 · one of two readings recorded this
Percentage of mice with liver metastasis
decreases, n = 60
Except for the negative group, the percentage of liver metastasis in the other 4 groups was 100%, 80%, 73.3% and 60%, respectively
PMID:19109874 · one of two readings recorded this
Serum galectin-3 concentration, MCP groups versus positive control
no effect
However, there was no significant difference between them
PMID:19109874 · one of two readings recorded this
Volume of implanted spleen tumor
decreases, p = 0.003
The volume of implanted tumor in middle and high MCP concentration groups was significantly smaller than that in positive control group (P = 0.019; P = 0.003)
PMID:19109874 · one of two readings recorded this
Volume of implanted spleen tumor
decreases, p = 0.019
The volume of implanted tumor in middle and high MCP concentration groups was significantly smaller than that in positive control group (P = 0.019; P = 0.003)
PMID:19109874 · one of two readings recorded this
Blood urea nitrogen
no effect
BUN (mM) | 7±1 | 72±17a | 18±2a,c | 62±4a,e | 16±1a,c,f
PMID:21494626 · one of two readings recorded this
Blood urea nitrogen
no effect
BUN (mM) | 7±1 | 72±17a | 18±2a,c | 62±4a,e | 16±1a,c,f
PMID:21494626 · one of two readings recorded this
Apoptotic cells
decreases
Apoptotic cells (number per fields) | 0.7±0.1 | 2.7±0.6a | 4.3±1.4a,b | 1.8±0.6a,d | 2.8±0.2a,d
PMID:21494626 · one of two readings recorded this
Apoptotic cells
no effect
Apoptotic cells (number per fields) | 0.7±0.1 | 2.7±0.6a | 4.3±1.4a,b | 1.8±0.6a,d | 2.8±0.2a,d
PMID:21494626 · one of two readings recorded this
Body weight
no effect
Body weight (g) | 23.8±0.4 | 21.6±0.4a | 23.1±0.9 | 23.6±0.7d | 22.4±2.0
PMID:21494626 · one of two readings recorded this
Body weight
increases
Body weight (g) | 23.8±0.4 | 21.6±0.4a | 23.1±0.9 | 23.6±0.7d | 22.4±2.0
PMID:21494626 · one of two readings recorded this
Collagen I area
decreases
Collagen I area (%) | 0.5±0.1 | 2.5±0.7a | 1.3±0.2a | 2.3±0.4a | 0.5±0.1b,e,f
PMID:21494626 · one of two readings recorded this
Collagen I area
no effect
Collagen I area (%) | 0.5±0.1 | 2.5±0.7a | 1.3±0.2a | 2.3±0.4a | 0.5±0.1b,e,f
PMID:21494626 · one of two readings recorded this
Collagen III area
no effect
Collagen III area (%) | 1.2±0.1 | 3.0±0.3a | 2.6±0.3a | 2.2±0.2a | 2.2±0.3b
PMID:21494626 · one of two readings recorded this
Collagen III area
no effect
Collagen III area (%) | 1.2±0.1 | 3.0±0.3a | 2.6±0.3a | 2.2±0.2a | 2.2±0.3b
PMID:21494626 · one of two readings recorded this
Galectin-3 positive interstitial cells per field
decreases, p = 0.01
(13.6±1.2 versus 23.8±3.1 positive interstitial cells/field respectively, p<0.01)
PMID:21494626 · one of two readings recorded this
Interstitial neutrophils per field
no effect
numbers of neutrophils in the interstitium (9.6±2.5 and 7.3±1.4 cells/field in FA-animals drinking normal and MCP water respectively) were unchanged
PMID:21494626 · one of two readings recorded this
Kidney/body weight ratio
no effect
Kidney/body weight (x100) | 0.55±0.03 | 0.87±0.04a | 0.50±0.02c | 0.69±0.05b,d,e | 0.52±0.03c,f
PMID:21494626 · one of two readings recorded this
Kidney/body weight ratio
decreases
Kidney/body weight (x100) | 0.55±0.03 | 0.87±0.04a | 0.50±0.02c | 0.69±0.05b,d,e | 0.52±0.03c,f
PMID:21494626 · one of two readings recorded this
Kidney weight
no effect
Kidney weight (g) | 0.13±0.01 | 0.19±0.01a | 0.12±0.01c | 0.16±0.01a,d,e | 0.11±0.01c,f
PMID:21494626 · one of two readings recorded this
Kidney weight
decreases
Kidney weight (g) | 0.13±0.01 | 0.19±0.01a | 0.12±0.01c | 0.16±0.01a,d,e | 0.11±0.01c,f
PMID:21494626 · one of two readings recorded this
Macrophage area (F4/80)
decreases
Macrophage area (%) | 0.4±0.1 | 0.2±0.1a | 6.5±1.0b | 0.3±0.1d | 3.8±0.5a,b,e,f
PMID:21494626 · one of two readings recorded this
Macrophage area (F4/80)
no effect
Macrophage area (%) | 0.4±0.1 | 0.2±0.1a | 6.5±1.0b | 0.3±0.1d | 3.8±0.5a,b,e,f
PMID:21494626 · one of two readings recorded this
PCNA positive cells two days after FA
decreases, p = 0.05
Kidneys from FA animals provided with MCP in the drinking water had significantly decreased numbers of PCNA positive cells (F, p<0.05)
PMID:21494626 · one of two readings recorded this
Proliferating cells
no effect
Proliferating cells (number per field) | 0.9±0.3 | 17.9±3.3a | 3.8±0.4a,b | 7.2±2.8a,c | 5.1±1.3a,b
PMID:21494626 · one of two readings recorded this
Proliferating cells
decreases
Proliferating cells (number per field) | 0.9±0.3 | 17.9±3.3a | 3.8±0.4a,b | 7.2±2.8a,c | 5.1±1.3a,b
PMID:21494626 · one of two readings recorded this
Renal alpha-SMA mRNA
decreases, p = 0.01
MCP caused significant attenuation of the increases for most of these fibrotic markers (α-SMA p<0.01; collagen I, fibronectin and TGFβ1 p<0.05)
PMID:21494626 · one of two readings recorded this
Renal collagen I, fibronectin and TGFβ1 mRNA
decreases, p = 0.05
MCP caused significant attenuation of the increases for most of these fibrotic markers (α-SMA p<0.01; collagen I, fibronectin and TGFβ1 p<0.05)
PMID:21494626 · one of two readings recorded this
Renal collagen III mRNA
no effect, p = 0.18
but again did not alter collagen III (p = 0.18)
PMID:21494626 · one of two readings recorded this
Renal galectin-1 and galectin-9 mRNA
no effect
Both galectin-1 and galectin-9 mRNA levels were upregulated in FA animals compared to sham controls in both the acute and recovery phases, but these increases were not significantly altered by MCP
PMID:21494626 · one of two readings recorded this
Renal galectin-3 mRNA
decreases
Administration of MCP (Group III) did not significantly alter galectin-3 mRNA levels at 2 days but there was a statistically significant reduction at day 14
PMID:21494626 · one of two readings recorded this
Renal galectin-3 mRNA
no effect
Administration of MCP (Group III) did not significantly alter galectin-3 mRNA levels at 2 days but there was a statistically significant reduction at day 14
PMID:21494626 · one of two readings recorded this
Renal IL-1β and TNF-α mRNA
decreases, p = 0.05
MCP led to significantly decreased levels of IL-1β and TNF-α, p<0.05)
PMID:21494626 · one of two readings recorded this
Renal MCP-1 and IL-6 mRNA
no effect
MCP-1 and IL-6 were both lower but this did not reach statistical significance
PMID:21494626 · one of two readings recorded this
serum creatinine and BUN at day 14 after folic acid
marginally higher with water than MCP water, not statistically significant
Not recorded as a finding: only sentence is agentless, joins creatinine and BUN, and reports a marginal difference that is not significant, with no two-sided statement.
Levels were marginally higher in those drinking normal rather than MCP-supplemented water, but this was not statistically significant (Table 1).
PMID:21494626 · one of two readings recorded this
Serum creatinine fold elevation versus sham at day 14
increases
creatinine elevated 1.7–1.9 fold; BUN up 2.1–2.3x
PMID:21494626 · one of two readings recorded this
Serum creatinine
no effect
Serum creatinine (µM) | 22±1 | 147±15 a | 40±1a,c | 157±8a,e | 37±2a,c,f
PMID:21494626 · one of two readings recorded this
Serum creatinine
no effect
Serum creatinine (µM) | 22±1 | 147±15 a | 40±1a,c | 157±8a,e | 37±2a,c,f
PMID:21494626 · one of two readings recorded this
BMDC CCR1 expression
decreases
Conversely, the expression of CCR1, which is reduced during DC maturation, was downregulated by RG-II treatment or LPS stimulation
PMID:23392255 · one of two readings recorded this
BMDC CCR7 expression
increases
Similar to the increased CCR7 expression observed in LPS-treated BMDCs, RG-II induced the upregulation of CCR7 expression in BMDCs
PMID:23392255 · one of two readings recorded this
BMDC CD40 expression
increases
RG-II also significantly enhanced CD40 expression
PMID:23392255 · one of two readings recorded this
BMDC CD86, MHC class I and MHC class II expression
increases
Flow cytometric analysis of MHC class and co-stimulatory molecule expression showed that a strong increase in the expression of CD86, MHC class I and MHC class II was induced by RG-II
PMID:23392255 · one of two readings recorded this
BMDC ERK1/2 and p38 MAPK phosphorylation
increases
The results showed that the phosphorylation of ERK1/2 and p38 MAPK was significantly induced by RG-II stimulation
PMID:23392255 · one of two readings recorded this
BMDC secretion of IL-10
no effect
RG-II enhanced the secretion of IL-12p70, IL-1β and TNF-α in BMDCs in a dose-dependent fashion, whereas RG-II had little effect on IL-10 production
PMID:23392255 · one of two readings recorded this
BMDC secretion of IL-12p70, IL-1β and TNF-α
increases
RG-II enhanced the secretion of IL-12p70, IL-1β and TNF-α in BMDCs in a dose-dependent fashion, whereas RG-II had little effect on IL-10 production
PMID:23392255 · one of two readings recorded this
CD86 and MHC class II upregulation in TLR4 knockout BMDCs
no effect
We observed that RG-II was able to induce upregulation of the maturation markers, CD86 and MHC class II, in BMDCs from wild-type (WT) and TLR2 knockout (KO) mice, but not in TLR4 KO mice
PMID:23392255 · one of two readings recorded this
Cell death of BMDCs (Annexin V and propidium iodide)
no effect
Flow cytometric analysis using Annexin V and propidium iodide staining showed no marked change in the percentage of dead cells until a concentration of 1 mg ml−1 RG-II was reached
PMID:23392255 · one of two readings recorded this
CTL response against EG7 cells
increases
Immunization of mice with OVA and RG-II-loaded BMDCs induced a strong CTL response against EG7 cells compared with mice immunized with OVA-pulsed BMDCs but not against the parental EL4 cells, as expected
PMID:23392255 · one of two readings recorded this
EG7 lymphoma tumour growth and survival in mice vaccinated with OVA-pulsed BMDCs plus RG-II, tumour volume from caliper axes
decreases, significantly slowed tumour growth at day 42, P<0.01, p = 0.01
Not recorded as a finding: no tumour-growth node; the intervention is RG-II-treated dendritic cells given with OVA antigen, not RG-II alone, so the comparator is not absence of the compound.
Figure 8b shows that immunized group with OVA/RG-II-pulsed BMDCs had significantly slowed tumor growth at day 42 (P<0.01) compared with the tumor growth pattern of others.
PMID:23392255 · one of two readings recorded this
EG7 tumor growth
decreases, p = 0.01
Figure 8b shows that immunized group with OVA/RG-II-pulsed BMDCs had significantly slowed tumor growth at day 42 (P<0.01) compared with the tumor growth pattern of others
PMID:23392255 · one of two readings recorded this
IFN-γ production by OVA-stimulated OT-1 T cells
increases
the combination OVA/RG-II-stimulated CTLs produced twofold higher IFN-γ than OVA-stimulated OT-1 T cells
PMID:23392255 · one of two readings recorded this
JNK, ERK and p38 MAPK phosphorylation in TLR4 knockout BMDCs
increases
RG-II triggered the phosphorylation of JNK, ERK and p38 MAPK in a TLR4-dependent manner
PMID:23392255 · one of two readings recorded this
Mice culled in control and nonpulsed BMDC groups
All control mice and mice injected with nonpulsed BMDCs were culled by day 62
PMID:23392255 · one of two readings recorded this
Mice culled in OVA-alone BMDC group
Three of the five mice injected with BMDCs pulsed with OVA alone without RG-II stimulation were culled by day 52
PMID:23392255 · one of two readings recorded this
NF-kB p65 nuclear translocation
increases
In addition, nuclear translocation of the p65 subunit was observed in the RG-II-treated BMDCs
PMID:23392255 · one of two readings recorded this
OVA-specific CD8+ T-cell proliferation
increases
Proliferation of transgenic OVA-specific CD8+ T cells co-cultured with OVA/RG-II-stimulated BMDCs was significantly increased compared with OVA-specific CD8+ T cells treated with OVA alone, as revealed by CFSE dilution
PMID:23392255 · one of two readings recorded this
RG-II-induced IL-12 secretion in presence of polymyxin B
increases
showed that RG-II still stimulates IL-12 expression in the presence of polymyxin B (Supplementary Figure S2)
PMID:23392255 · one of two readings recorded this
RG-II-induced IL-12 secretion under CD14 or LBP depletion
decreases
In CD14- or LBP-depleted conditions, RG-II-induced secretion of IL-12 was significantly attenuated compared with control antibody-depleted conditions
PMID:23392255 · one of two readings recorded this
RG-II-mediated IL-12 secretion in MyD88 or TRIF knockout BMDCs
decreases
we found that RG-II-mediated IL-12 secretion is partially impaired in MyD88 or TRIF knockout BMDCs compared with normal BMDCs
PMID:23392255 · one of two readings recorded this
Survival to day 65
increases
All mice vaccinated with BMDCs pulsed with OVA+RG-II (0.5 mg ml−1) and four of the five mice vaccinated with BMDCs pulsed with OVA+RG-II (1 mg ml−1) survived until day 65
PMID:23392255 · one of two readings recorded this
Survival to day 65
increases
All mice vaccinated with BMDCs pulsed with OVA+RG-II (0.5 mg ml−1) and four of the five mice vaccinated with BMDCs pulsed with OVA+RG-II (1 mg ml−1) survived until day 65
PMID:23392255 · one of two readings recorded this
body weight gain in grams over 2, 4 and 6 weeks in rats fed a high-fat diet with apple pectin versus a fibre-free diet; also liver fat, liver cholesterol, liver triglycerides, and plasma cholesterol measured per time point
decreases, 239 g vs. 282 g for the fibre-free diet after 6 weeks, p = 0.0036, p = 0.0036
Not recorded as a finding: this platform holds no node for the endpoint
Rats given dietary fibre had a lower weight gain than those given a fibre-free diet throughout the experimental period, and pectin had most pronounced effects (62 g vs. 78 g for the fibre-free diet, p = 0.0218 after 2 weeks, 172 g vs. 196 g for the fibre-free diet after 4 weeks, p = 0.0314 and 239 g vs. 282 g for the fibre-free diet after 6 weeks, p = 0.0036).
PMID:24236183 · one of two readings recorded this
Caecal Akkermansia abundance
decreases, p = 0.005
The abundance of Akkermansia was higher in the group fed the fibre-free diet when compared with the groups fed pectin or guar gum (p<0.005)
PMID:24236183 · one of two readings recorded this
Caecal Bacteroides abundance
increases, p = 0.05
The abundance of Bacteroides was higher in the group fed guar gum than pectin or the fibre-free diet (p<0.05)
PMID:24236183 · one of two readings recorded this
Caecal pool acetic acid
n = 7
High | Fibre-free | 64±6a | 17±1a | 13±1a | 7±0.7ab | 114±9a | 0.9±0.1a | 0.6±0.1a
PMID:24236183 · one of two readings recorded this
Caecal pool acetic acid
n = 7
Low | Fibre-free | 77±6a | 12±2a | 10±0.7a | 5±0.8a | 90±9a | 0.7±0.1 | 0.4±0.05a
PMID:24236183 · one of two readings recorded this
Caecal pool acetic acid
increases, n = 7
Pectin | 146±31ab | 25±5b | 14±3a | 6±0.9a | 191±39ab | 2±0.4ab | 4±2ab
PMID:24236183 · one of two readings recorded this
Caecal pool acetic acid
increases, n = 7
Pectin | 198±24c | 30±4bc | 22±2b | 10±0.8b | 260±30b | 1.8±0.4 | 0.9±0.2b
PMID:24236183 · one of two readings recorded this
Caecal pool succinic acid
increases, n = 7
Mixture | 192±27b* | 46±8c* | 25±3b | 9±1ab | 272±36b | 3±0.8b | 17±5b*
PMID:24236183 · one of two readings recorded this
Correlation of liver cholesterol with length of experiment
increases, p = 0.001
the amount increased with time (correlation factor 0.86, 0.82 and 0.84, respectively, p<0.001)
PMID:24236183 · one of two readings recorded this
Correlation of liver fat with length of experiment
increases, p = 0.001
the amount increased with time (correlation factor 0.86, 0.82 and 0.84, respectively, p<0.001)
PMID:24236183 · one of two readings recorded this
Correlation of liver triglycerides with length of experiment
increases, p = 0.001
the amount increased with time (correlation factor 0.86, 0.82 and 0.84, respectively, p<0.001)
PMID:24236183 · one of two readings recorded this
Correlation of liver weight with length of experiment
increases, p = 0.001
A clear correlation was seen between the length of the experimental time and the liver weights (correlation factor 0.917 and p<0.001)
PMID:24236183 · one of two readings recorded this
Correlation of serum acetic acid with length of experiment
increases, p = 0.001
A correlation was found between the length of the experiment and the concentration of acetic and propionic acids (correlation factors 0.49 and 0.42, respectively, p<0.001)
PMID:24236183 · one of two readings recorded this
Correlation of serum propionic acid with length of experiment
increases, p = 0.001
A correlation was found between the length of the experiment and the concentration of acetic and propionic acids (correlation factors 0.49 and 0.42, respectively, p<0.001)
PMID:24236183 · one of two readings recorded this
Liver cholesterol amount
n = 7
High | Fibre-free | 1.59±0.1a*** | 422±26a*** | 503±52a*** | 4.0±0.2a***
PMID:24236183 · one of two readings recorded this
Liver cholesterol amount
n = 7
Low | Fibre-free | 0.31±0.03a | 79±3a | 168±19a | 2.9±0.1
PMID:24236183 · one of two readings recorded this
Liver cholesterol amount
decreases, n = 7
Guar gum | 1.10±0.1b*** | 327±26b*** | 296±25b*** | 3.4±0.1b**
PMID:24236183 · one of two readings recorded this
Liver cholesterol amount
n = 7
Guar gum | 0.24±0.01ab | 65±3ab | 112±5b | 2.8±0.07
PMID:24236183 · one of two readings recorded this
Liver cholesterol amount
decreases, n = 7
Mixture | 0.90±0.02b*** | 293±17b*** | 282±14b*** | 3.8±0.1ab***
PMID:24236183 · one of two readings recorded this
Liver cholesterol amount
decreases, n = 7
Mixture | 0.23±0.01b | 63±1b | 106±2b | 2.7±0.08
PMID:24236183 · one of two readings recorded this
Liver cholesterol amount
decreases, n = 7
Pectin | 0.86±0.05b*** | 252±13b*** | 204±12b** | 3.3±0.1b
PMID:24236183 · one of two readings recorded this
Liver cholesterol amount
n = 7
Pectin | 0.23±0.02b | 65±6ab | 128±10ab | 3.0±0.1
PMID:24236183 · one of two readings recorded this
Liver cholesterol reduction with dietary fibre in high-fat diet
decreases, p = 0.02
while the amount of cholesterol decreased by 31±3% (p<0.02)
PMID:24236183 · one of two readings recorded this
Liver fat content
n = 7
High | Fibre-free | 1.59±0.1a*** | 422±26a*** | 503±52a*** | 4.0±0.2a***
PMID:24236183 · one of two readings recorded this
Liver fat content
n = 7
Low | Fibre-free | 0.31±0.03a | 79±3a | 168±19a | 2.9±0.1
PMID:24236183 · one of two readings recorded this
Liver fat content
decreases, n = 7
Guar gum | 1.10±0.1b*** | 327±26b*** | 296±25b*** | 3.4±0.1b**
PMID:24236183 · one of two readings recorded this
Liver fat content
n = 7
Guar gum | 0.24±0.01ab | 65±3ab | 112±5b | 2.8±0.07
PMID:24236183 · one of two readings recorded this
Liver fat content
decreases, n = 7
Mixture | 0.90±0.02b*** | 293±17b*** | 282±14b*** | 3.8±0.1ab***
PMID:24236183 · one of two readings recorded this
Liver fat content
decreases, n = 7
Mixture | 0.23±0.01b | 63±1b | 106±2b | 2.7±0.08
PMID:24236183 · one of two readings recorded this
Liver fat content
decreases, n = 7
Pectin | 0.86±0.05b*** | 252±13b*** | 204±12b** | 3.3±0.1b
PMID:24236183 · one of two readings recorded this
Liver fat content
decreases, n = 7
Pectin | 0.23±0.02b | 65±6ab | 128±10ab | 3.0±0.1
PMID:24236183 · one of two readings recorded this
Liver fat reduction with dietary fibre in high-fat diet
decreases, p = 0.001
the addition of dietary fibre resulted in 40±3% lower liver fat (p<0.001)
PMID:24236183 · one of two readings recorded this
Liver triglyceride amount
n = 7
High | Fibre-free | 1.59±0.1a*** | 422±26a*** | 503±52a*** | 4.0±0.2a***
PMID:24236183 · one of two readings recorded this
Liver triglyceride amount
n = 7
Low | Fibre-free | 0.31±0.03a | 79±3a | 168±19a | 2.9±0.1
PMID:24236183 · one of two readings recorded this
Liver triglyceride amount
decreases, n = 7
Guar gum | 1.10±0.1b*** | 327±26b*** | 296±25b*** | 3.4±0.1b**
PMID:24236183 · one of two readings recorded this
Liver triglyceride amount
decreases, n = 7
Guar gum | 0.24±0.01ab | 65±3ab | 112±5b | 2.8±0.07
PMID:24236183 · one of two readings recorded this
Liver triglyceride amount
decreases, n = 7
Mixture | 0.90±0.02b*** | 293±17b*** | 282±14b*** | 3.8±0.1ab***
PMID:24236183 · one of two readings recorded this
Liver triglyceride amount
decreases, n = 7
Mixture | 0.23±0.01b | 63±1b | 106±2b | 2.7±0.08
PMID:24236183 · one of two readings recorded this
Liver triglyceride amount
decreases, n = 7
Pectin | 0.86±0.05b*** | 252±13b*** | 204±12b** | 3.3±0.1b
PMID:24236183 · one of two readings recorded this
Liver triglyceride amount
n = 7
Pectin | 0.23±0.02b | 65±6ab | 128±10ab | 3.0±0.1
PMID:24236183 · one of two readings recorded this
Liver weight
n = 7
High | Fibre-free | 78±4a ** | 1.7±0.1a | 0.7±0.03a | 7.1±0.06 | 10.6±0.4* | 0.64±0.03
PMID:24236183 · one of two readings recorded this
Liver weight
n = 7
Low | Fibre-free | 59±2 | 1.4±0.1a | 0.6±0.02a | 6.9±0.11 | 8.3±0.3 | 0.58±0.04
PMID:24236183 · one of two readings recorded this
Liver weight
decreases, n = 7
Pectin | 62±4b | 2.9±0.4ab | 1.1±0.08b * | 7.0±0.1 | 8.6±0.3 | 0.58±0.03
PMID:24236183 · one of two readings recorded this
Liver weight
decreases, p = 0.0437
17.9 g vs. 15.5 g after 4 weeks [p = 0.0437]
PMID:24236183 · one of two readings recorded this
Liver weight
decreases, p = 0.0086
23.7 g vs. 19.7 g after 6 weeks [p = 0.0086]
PMID:24236183 · one of two readings recorded this
Liver weight
n = 7
Pectin | 58±3 | 3.2±0.3b | 0.8±0.04b | 7.0±0.05 | 7.1±0.5 | 0.59±0.2
PMID:24236183 · one of two readings recorded this
Plasma cholesterol
n = 7
High | Fibre-free | 1.59±0.1a*** | 422±26a*** | 503±52a*** | 4.0±0.2a***
PMID:24236183 · one of two readings recorded this
Plasma cholesterol
n = 7
Low | Fibre-free | 0.31±0.03a | 79±3a | 168±19a | 2.9±0.1
PMID:24236183 · one of two readings recorded this
Plasma cholesterol
decreases, n = 7
Guar gum | 1.10±0.1b*** | 327±26b*** | 296±25b*** | 3.4±0.1b**
PMID:24236183 · one of two readings recorded this
Plasma cholesterol
no effect, n = 7
Guar gum | 0.24±0.01ab | 65±3ab | 112±5b | 2.8±0.07
PMID:24236183 · one of two readings recorded this
Plasma cholesterol
n = 7
Mixture | 0.90±0.02b*** | 293±17b*** | 282±14b*** | 3.8±0.1ab***
PMID:24236183 · one of two readings recorded this
Plasma cholesterol
no effect, n = 7
Mixture | 0.23±0.01b | 63±1b | 106±2b | 2.7±0.08
PMID:24236183 · one of two readings recorded this
Plasma cholesterol
decreases, n = 7
Pectin | 0.86±0.05b*** | 252±13b*** | 204±12b** | 3.3±0.1b
PMID:24236183 · one of two readings recorded this
Plasma cholesterol
no effect, n = 7
Pectin | 0.23±0.02b | 65±6ab | 128±10ab | 3.0±0.1
PMID:24236183 · one of two readings recorded this
Serum acetic acid
n = 7
High | Fibre-free | 648±27a | 53±4a | 27±2 | 94±5 | 823±32a
PMID:24236183 · one of two readings recorded this
Serum acetic acid
n = 7
Low | Fibre-free | 723±46a | 49±7a | 26±4 | 78±2a | 876±59a
PMID:24236183 · one of two readings recorded this
Serum acetic acid
n = 7
Guar gum | 655±22a | 84±9ab | 32±5 | 87±6 | 859±32a
PMID:24236183 · one of two readings recorded this
Serum acetic acid
n = 7
Guar gum | 723±39a | 129±20b | 48±7 | 126±16b | 1026±73a
PMID:24236183 · one of two readings recorded this
Serum acetic acid
increases, n = 7
Mixture | 891±54b | 115±13b | 39±5 | 72±4 | 1116±71b
PMID:24236183 · one of two readings recorded this
Serum acetic acid
n = 7
Mixture | 766±24a | 71±11a | 36±8 | 93±8ab | 982±53a
PMID:24236183 · one of two readings recorded this
Serum acetic acid
increases, n = 7
Pectin | 1033±61b | 82±13ab | 28±3 | 83±11 | 1226±79b
PMID:24236183 · one of two readings recorded this
Serum acetic acid
increases, n = 7
Pectin | 1111±81b | 86±9ab | 45±5 | 94±7ab | 1336±97b
PMID:24236183 · one of two readings recorded this
Serum butyric acid
n = 7
Pectin | 1033±61b | 82±13ab | 28±3 | 83±11 | 1226±79b
PMID:24236183 · one of two readings recorded this
Serum butyric acid
n = 7
Pectin | 1111±81b | 86±9ab | 45±5 | 94±7ab | 1336±97b
PMID:24236183 · one of two readings recorded this
Serum MCP-1
p = 0.05
The fibre-free group fed HFD for 6 weeks had a higher concentration (83.1 ng/L) compared with the fibre groups fed LFD for 2 weeks and guar gum groups fed HFD for 2 and 4 weeks (p<0.05)
PMID:24236183 · one of two readings recorded this
Serum MCP-1
The lowest concentration of MCP-1 was seen in the group fed guar gum in LFD (23.5 ng/L)
PMID:24236183 · one of two readings recorded this
Serum propionic acid
increases, n = 7
Guar gum | 723±39a | 129±20b | 48±7 | 126±16b | 1026±73a
PMID:24236183 · one of two readings recorded this
Serum propionic acid
n = 7
Pectin | 1111±81b | 86±9ab | 45±5 | 94±7ab | 1336±97b
PMID:24236183 · one of two readings recorded this
Weight gain
n = 7
High | Fibre-free | 78±4a ** | 1.7±0.1a | 0.7±0.03a | 7.1±0.06 | 10.6±0.4* | 0.64±0.03
PMID:24236183 · one of two readings recorded this
Weight gain
n = 7
Low | Fibre-free | 59±2 | 1.4±0.1a | 0.6±0.02a | 6.9±0.11 | 8.3±0.3 | 0.58±0.04
PMID:24236183 · one of two readings recorded this
Weight gain
n = 7
Guar gum | 73±2 | 4.3±0.6b | 1.1±0.06b | 7.2±0.07 | 9.5±0.3* | 0.58±0.02
PMID:24236183 · one of two readings recorded this
Weight gain
n = 7
Guar gum | 61±3 | 3.8±0.3bc | 1.0±0.04c | 7.0±0.08 | 7.6±0.3 | 0.58±0.03
PMID:24236183 · one of two readings recorded this
Weight gain
n = 7
Mixture | 68±4 | 4.5±0.5b * | 1.2±0.09b * | 6.9±0.1 | 9.6±0.6*** | 0.61±0.02
PMID:24236183 · one of two readings recorded this
Weight gain
n = 7
Mixture | 60±3 | 2.8±0.3b | 0.9±0.04bc | 7.1±0.04 | 7.1±0.1 | 0.59±0.02
PMID:24236183 · one of two readings recorded this
Weight gain
decreases, n = 7
Pectin | 62±4b | 2.9±0.4ab | 1.1±0.08b * | 7.0±0.1 | 8.6±0.3 | 0.58±0.03
PMID:24236183 · one of two readings recorded this
Weight gain
decreases, p = 0.0314
172 g vs. 196 g for the fibre-free diet after 4 weeks, p = 0.0314
PMID:24236183 · one of two readings recorded this
Weight gain
decreases, p = 0.0036
239 g vs. 282 g for the fibre-free diet after 6 weeks, p = 0.0036
PMID:24236183 · one of two readings recorded this
Weight gain
n = 7
Pectin | 58±3 | 3.2±0.3b | 0.8±0.04b | 7.0±0.05 | 7.1±0.5 | 0.59±0.2
PMID:24236183 · one of two readings recorded this
Body weight gain correlation with dietary pectin amount
decreases, p = 0.001
body weight gain correlated negatively with the amount of pectin in the diet in both cohorts (r = -0.688 and -0.752, respectively, both P<0.001)
PMID:25602757 · one of two readings recorded this
Body weight gain correlation with dietary pectin amount
decreases, p = 0.001
body weight gain correlated negatively with the amount of pectin in the diet in both cohorts (r = -0.688 and -0.752, respectively, both P<0.001)
PMID:25602757 · one of two readings recorded this
Caecum length
increases
Caecum length (mm) | 37.5a ±0.9 | 44.1b ±1.9 | 50.6c ±1.7 | 56.9d ±1.3 | 0.874 *** | 35.9a ±1.1 | 44.4b ±1.5 | 52.8c ±1.9 | 59.4d ±1.7 | 0.902 ***
PMID:25602757 · one of two readings recorded this
Caecum length
increases
Caecum length (mm) | 37.5a ±0.9 | 44.1b ±1.9 | 50.6c ±1.7 | 56.9d ±1.3 | 0.874 *** | 35.9a ±1.1 | 44.4b ±1.5 | 52.8c ±1.9 | 59.4d ±1.7 | 0.902 ***
PMID:25602757 · one of two readings recorded this
Caecum mucosa depth
no effect
Caecum mucosa depth | 184.3a ±8.3 | 188.6a ±7.7 | 209.6ab ±7.6 | 231.8b ±7.2 | 0.681 *** | 209.5 ±15.1 | 206.4 ±7.9 | 217.8 ±12.4 | 215.8 ±8.2 | 0.115
PMID:25602757 · one of two readings recorded this
Caecum mucosa depth
increases
Caecum mucosa depth | 184.3a ±8.3 | 188.6a ±7.7 | 209.6ab ±7.6 | 231.8b ±7.2 | 0.681 *** | 209.5 ±15.1 | 206.4 ±7.9 | 217.8 ±12.4 | 215.8 ±8.2 | 0.115
PMID:25602757 · one of two readings recorded this
Caecum weight
increases
Caecum weight (g) | 3.0a ±0.2 | 4.7b ±0.2 | 5.4b ±0.4 | 7.0c ±0.5 | 0.834 *** | 3.5a ±0.2 | 5.4b ±0.3 | 6.8b ±0.5 | 9.3c ±0.6 | 0.876 ***
PMID:25602757 · one of two readings recorded this
Caecum weight
increases
Caecum weight (g) | 3.0a ±0.2 | 4.7b ±0.2 | 5.4b ±0.4 | 7.0c ±0.5 | 0.834 *** | 3.5a ±0.2 | 5.4b ±0.3 | 6.8b ±0.5 | 9.3c ±0.6 | 0.876 ***
PMID:25602757 · one of two readings recorded this
Colon length
no effect
Colon length (mm) | 157a ±4 | 176ab ±7 | 183ab ±9 | 194b ±8 | 0.561 *** | 166 ±5 | 171 ±2 | 174 ±4 | 174 ±6 | 0.157
PMID:25602757 · one of two readings recorded this
Colon length
increases
Colon length (mm) | 157a ±4 | 176ab ±7 | 183ab ±9 | 194b ±8 | 0.561 *** | 166 ±5 | 171 ±2 | 174 ±4 | 174 ±6 | 0.157
PMID:25602757 · one of two readings recorded this
Colon weight
no effect
Colon weight (g) | 2.4a ±0.2 | 3.6ab ±0.3 | 4.1b ±0.5 | 4.4b ±0.4 | 0.560 *** | 2.3a ±0.3 | 4.2b ±0.3 | 3.9b ±0.5 | 3.5ab ±0.4 | 0.297
PMID:25602757 · one of two readings recorded this
Colon weight
increases
Colon weight (g) | 2.4a ±0.2 | 3.6ab ±0.3 | 4.1b ±0.5 | 4.4b ±0.4 | 0.560 *** | 2.3a ±0.3 | 4.2b ±0.3 | 3.9b ±0.5 | 3.5ab ±0.4 | 0.297
PMID:25602757 · one of two readings recorded this
Distal colon mucosa depth
no effect
Distal colon mucosa depth | 215.7 ±6.0 | 221.8 ±21.5 | 236.2 ±21.2 | 230.4 ±14.9 | 0.195 | 224.8 ±6.9 | 238.0 ±11.8 | 252.2 ±16.1 | 251.1 ±11.0 | 0.340
PMID:25602757 · one of two readings recorded this
Distal colon mucosa depth
no effect
Distal colon mucosa depth | 215.7 ±6.0 | 221.8 ±21.5 | 236.2 ±21.2 | 230.4 ±14.9 | 0.195 | 224.8 ±6.9 | 238.0 ±11.8 | 252.2 ±16.1 | 251.1 ±11.0 | 0.340
PMID:25602757 · one of two readings recorded this
Distal ileum crypt depth
increases
Distal ileum crypt depth | 150.0a ±8.2 | 158.5a ±11.2 | 213.8b ±13.4 | 179.8ab ±13.6 | 0.491 * | 150.7a ±12.7 | 153.3a ±16.1 | 172.7a ±12.4 | 263.4b ±27.4 | 0.662 ***
PMID:25602757 · one of two readings recorded this
Distal ileum crypt depth
increases
Distal ileum crypt depth | 150.0a ±8.2 | 158.5a ±11.2 | 213.8b ±13.4 | 179.8ab ±13.6 | 0.491 * | 150.7a ±12.7 | 153.3a ±16.1 | 172.7a ±12.4 | 263.4b ±27.4 | 0.662 ***
PMID:25602757 · one of two readings recorded this
Distal ileum villus height
no effect
Distal ileum villus height | 263.5 ±20.7 | 335.8 ±34.3 | 382.4 ±48.8 | 311.6 ±25.0 | 0.173 | 295.9 ±11.8 | 315.9 ±23.3 | 281.3 ±6.5 | 338.7 ±20.6 | 0.205
PMID:25602757 · one of two readings recorded this
Distal ileum villus height
no effect
Distal ileum villus height | 263.5 ±20.7 | 335.8 ±34.3 | 382.4 ±48.8 | 311.6 ±25.0 | 0.173 | 295.9 ±11.8 | 315.9 ±23.3 | 281.3 ±6.5 | 338.7 ±20.6 | 0.205
PMID:25602757 · one of two readings recorded this
Jejunum crypt depth
increases
Jejunum crypt depth | 172.1 ±17.0 | 159.7 ±6.1 | 195.4 ±17.5 | 216.2 ±16.4 | 0.440 * | 149.2a ±9.5 | 158.5a ±8.6 | 183.8a ±16.2 | 292.5b ±16.8 | 0.815 ***
PMID:25602757 · one of two readings recorded this
Jejunum crypt depth
increases
Jejunum crypt depth | 172.1 ±17.0 | 159.7 ±6.1 | 195.4 ±17.5 | 216.2 ±16.4 | 0.440 * | 149.2a ±9.5 | 158.5a ±8.6 | 183.8a ±16.2 | 292.5b ±16.8 | 0.815 ***
PMID:25602757 · one of two readings recorded this
Jejunum villus height
increases
Jejunum villus height | 583.5 ±47.2 | 612.3 ±15.2 | 647.0 ±21.1 | 685.9 ±18.9 | 0.499 * | 539.9 ±25.5 | 630.7 ±40.1 | 661.2 ±39.9 | 672.1 ±63.7 | 0.483 *
PMID:25602757 · one of two readings recorded this
Jejunum villus height
increases
Jejunum villus height | 583.5 ±47.2 | 612.3 ±15.2 | 647.0 ±21.1 | 685.9 ±18.9 | 0.499 * | 539.9 ±25.5 | 630.7 ±40.1 | 661.2 ±39.9 | 672.1 ±63.7 | 0.483 *
PMID:25602757 · one of two readings recorded this
Plasma PYY correlation with caecum weight
increases, p = 0.001
plasma PYY correlated with the amount of pectin in the diet (P<0.001; Fig. 4d) and with the weights of small intestine (r = 0.720, P<0.001) and caecum (r = 0.723, P<0.001), but not colon (r = 0.240)
PMID:25602757 · one of two readings recorded this
Plasma PYY correlation with caecum weight
increases, p = 0.001
plasma PYY correlated with the amount of pectin in the diet (P<0.001; Fig. 4b) and with the weights of small intestine (r = 0.794, P<0.001), caecum (r = 0.721, P<0.001) and colon (r = 0.444, P<0.01)
PMID:25602757 · one of two readings recorded this
Plasma PYY correlation with colon weight
no effect
plasma PYY correlated with the amount of pectin in the diet (P<0.001; Fig. 4d) and with the weights of small intestine (r = 0.720, P<0.001) and caecum (r = 0.723, P<0.001), but not colon (r = 0.240)
PMID:25602757 · one of two readings recorded this
Plasma PYY correlation with colon weight
increases, p = 0.01
plasma PYY correlated with the amount of pectin in the diet (P<0.001; Fig. 4b) and with the weights of small intestine (r = 0.794, P<0.001), caecum (r = 0.721, P<0.001) and colon (r = 0.444, P<0.01)
PMID:25602757 · one of two readings recorded this
Plasma PYY correlation with cumulative food intake
decreases, p = 0.01
and correlated negatively with cumulative food intake (r = -0.451, P<0.01)
PMID:25602757 · one of two readings recorded this
Plasma PYY correlation with cumulative food intake
decreases, p = 0.001
and correlated negatively with cumulative food intake (r = -0.745, P<0.001)
PMID:25602757 · one of two readings recorded this
Plasma PYY correlation with small intestine weight
increases, p = 0.001
plasma PYY correlated with the amount of pectin in the diet (P<0.001; Fig. 4d) and with the weights of small intestine (r = 0.720, P<0.001) and caecum (r = 0.723, P<0.001), but not colon (r = 0.240)
PMID:25602757 · one of two readings recorded this
Plasma PYY correlation with small intestine weight
increases, p = 0.001
plasma PYY correlated with the amount of pectin in the diet (P<0.001; Fig. 4b) and with the weights of small intestine (r = 0.794, P<0.001), caecum (r = 0.721, P<0.001) and colon (r = 0.444, P<0.01)
PMID:25602757 · one of two readings recorded this
Plasma total GLP-1 correlation with cumulative food intake
decreases, p = 0.001
Plasma total GLP-1 correlated negatively with cumulative food intake in both the 8-day and 28-day cohorts (r = -0.585 and -0.541, respectively; P<0.001)
PMID:25602757 · one of two readings recorded this
Plasma total GLP-1 correlation with cumulative food intake
decreases, p = 0.001
Plasma total GLP-1 correlated negatively with cumulative food intake in both the 8-day and 28-day cohorts (r = -0.585 and -0.541, respectively; P<0.001)
PMID:25602757 · one of two readings recorded this
Proximal colon mucosa depth
no effect
Proximal colon mucosa depth | 151.7 ±8.4 | 193.6 ±17.1 | 176.2 ±9.7 | 188.8 ±13.7 | 0.241 | 178.7 ±12.7 | 209.8 ±19.5 | 210.1 ±10.0 | 210.2 ±9.3 | 0.308
PMID:25602757 · one of two readings recorded this
Proximal colon mucosa depth
no effect
Proximal colon mucosa depth | 151.7 ±8.4 | 193.6 ±17.1 | 176.2 ±9.7 | 188.8 ±13.7 | 0.241 | 178.7 ±12.7 | 209.8 ±19.5 | 210.1 ±10.0 | 210.2 ±9.3 | 0.308
PMID:25602757 · one of two readings recorded this
Small intestine length
increases
Small intestine length (mm) | 1043a ±14 | 1057ab ±13 | 1123bc ±21 | 1149c ±29 | 0.617 *** | 1086a ±11 | 1105ab ±13 | 1154bc ±19 | 1184c ±16 | 0.688 ***
PMID:25602757 · one of two readings recorded this
Small intestine length
increases
Small intestine length (mm) | 1043a ±14 | 1057ab ±13 | 1123bc ±21 | 1149c ±29 | 0.617 *** | 1086a ±11 | 1105ab ±13 | 1154bc ±19 | 1184c ±16 | 0.688 ***
PMID:25602757 · one of two readings recorded this
Small intestine weight
increases
Small intestine weight (g) | 8.4a ±0.4 | 10.0b ±0.4 | 11.6c ±0.3 | 13.8d ±0.3 | 0.910 *** | 9.3a ±0.4 | 10.5ab ±0.3 | 11.6b ±0.4 | 13.3c ±0.5 | 0.808 ***
PMID:25602757 · one of two readings recorded this
Small intestine weight
increases
Small intestine weight (g) | 8.4a ±0.4 | 10.0b ±0.4 | 11.6c ±0.3 | 13.8d ±0.3 | 0.910 *** | 9.3a ±0.4 | 10.5ab ±0.3 | 11.6b ±0.4 | 13.3c ±0.5 | 0.808 ***
PMID:25602757 · one of two readings recorded this
Stomach weight
no effect
Stomach weight (g) | 6.3 ±0.5 | 5.4 ±0.4 | 6.5 ±0.7 | 5.2 ±0.3 | -0.153 | 4.8 ±0.8 | 6.0 ±0.8 | 6.1 ±0.7 | 5.8 ±0.7 | 0.168
PMID:25602757 · one of two readings recorded this
Stomach weight
no effect
Stomach weight (g) | 6.3 ±0.5 | 5.4 ±0.4 | 6.5 ±0.7 | 5.2 ±0.3 | -0.153 | 4.8 ±0.8 | 6.0 ±0.8 | 6.1 ±0.7 | 5.8 ±0.7 | 0.168
PMID:25602757 · one of two readings recorded this
Whole gut weight
increases
Whole gut weight (g) | 27.7a ±1.5 | 30.6ab ±1.3 | 34.4bc ±1.1 | 36.6c ±1.0 | 0.716 *** | 30.6a ±1.5 | 35.0ab ±1.4 | 35.8ab ±1.2 | 39.2b ±1.9 | 0.589 ***
PMID:25602757 · one of two readings recorded this
Whole gut weight
increases
Whole gut weight (g) | 27.7a ±1.5 | 30.6ab ±1.3 | 34.4bc ±1.1 | 36.6c ±1.0 | 0.716 *** | 30.6a ±1.5 | 35.0ab ±1.4 | 35.8ab ±1.2 | 39.2b ±1.9 | 0.589 ***
PMID:25602757 · one of two readings recorded this
Blood glucose
High | Fibre-free | 158 (23) | 3.8 (1.0) | 14.7 (3.1) | 0.76 (0.1) | 10 (1.1)
PMID:25973610 · one of two readings recorded this
Blood glucose
Low | Fibre-free | 128 (14) | 2.5 (0.3) | 9.81 (0.8) | 0.72 (0.1) | 10 (1.4)
PMID:25973610 · one of two readings recorded this
Blood glucose
decreases
HM Pectin | 118 (6) *** | 2.0 (0.5) *** | 10.8 (0.9) *** | 0.61 (0.1) * | 7.9 (0.4) ***
PMID:25973610 · one of two readings recorded this
Blood glucose
no effect
HM Pectin | 112 (16) | 2.0 (0.8) | 9.6 (1.2) | 0.59 (0.7) * | 9.1 (0.8)
PMID:25973610 · one of two readings recorded this
Blood glucose
decreases
LM Pectin | 96 (11) *** | 1.4 (0.3) *** | 11.0 (1.2) *** | 0.63 (0.1) | 8.3 (0.5) **
PMID:25973610 · one of two readings recorded this
Blood glucose
decreases
LM Pectin | 89 (13) *** | 1.6 (0.6) | 8.2 (0.7) | 0.54 (0.1) ** | 8.6 (0.8) *
PMID:25973610 · one of two readings recorded this
Caecal Akkermansia abundance
increases
where both guar gum and pectin increased Akkermansia in the high-fat setting
PMID:25973610 · one of two readings recorded this
Caecal Bifidobacterium abundance
no effect
Bifidobacterium was significantly increased by all preparations of guar gum, while pectin did not appear to have this bifidogenic effect
PMID:25973610 · one of two readings recorded this
Caecal Lactobacillus and Bacteroides abundance
no effect
The fibre preparations did not alter Lactobacillus or Bacteroides levels
PMID:25973610 · one of two readings recorded this
Epididymal fat weight
High | Fibre-free | 158 (23) | 3.8 (1.0) | 14.7 (3.1) | 0.76 (0.1) | 10 (1.1)
PMID:25973610 · one of two readings recorded this
Epididymal fat weight
Low | Fibre-free | 128 (14) | 2.5 (0.3) | 9.81 (0.8) | 0.72 (0.1) | 10 (1.4)
PMID:25973610 · one of two readings recorded this
Epididymal fat weight
decreases
HM Pectin | 118 (6) *** | 2.0 (0.5) *** | 10.8 (0.9) *** | 0.61 (0.1) * | 7.9 (0.4) ***
PMID:25973610 · one of two readings recorded this
Epididymal fat weight
no effect
HM Pectin | 112 (16) | 2.0 (0.8) | 9.6 (1.2) | 0.59 (0.7) * | 9.1 (0.8)
PMID:25973610 · one of two readings recorded this
Epididymal fat weight
decreases
LM Pectin | 96 (11) *** | 1.4 (0.3) *** | 11.0 (1.2) *** | 0.63 (0.1) | 8.3 (0.5) **
PMID:25973610 · one of two readings recorded this
Epididymal fat weight
no effect
LM Pectin | 89 (13) *** | 1.6 (0.6) | 8.2 (0.7) | 0.54 (0.1) ** | 8.6 (0.8) *
PMID:25973610 · one of two readings recorded this
Sources cited
1 paper
- Subject
- pectin
- Findings
- 3
- Papers
- 1
Other names
5 names
Resolves to: pectin
- Also called
- pectic substancepectinsPoly(1,4-alpha-D-galacturonide)poly[(1->4)-alpha-D-GalpA]poly[(1→4)-α-D-GalpA]